1. Home
  2. KRRO vs MXE Comparison

KRRO vs MXE Comparison

Compare KRRO & MXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • MXE
  • Stock Information
  • Founded
  • KRRO 2014
  • MXE 1990
  • Country
  • KRRO United States
  • MXE United States
  • Employees
  • KRRO N/A
  • MXE N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • MXE Finance Companies
  • Sector
  • KRRO Health Care
  • MXE Finance
  • Exchange
  • KRRO Nasdaq
  • MXE Nasdaq
  • Market Cap
  • KRRO 58.6M
  • MXE 50.0M
  • IPO Year
  • KRRO 2019
  • MXE N/A
  • Fundamental
  • Price
  • KRRO $5.59
  • MXE $11.86
  • Analyst Decision
  • KRRO Buy
  • MXE
  • Analyst Count
  • KRRO 10
  • MXE 0
  • Target Price
  • KRRO $74.17
  • MXE N/A
  • AVG Volume (30 Days)
  • KRRO 1.0M
  • MXE 5.8K
  • Earning Date
  • KRRO 11-12-2025
  • MXE 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • MXE 2.66%
  • EPS Growth
  • KRRO N/A
  • MXE N/A
  • EPS
  • KRRO N/A
  • MXE N/A
  • Revenue
  • KRRO $7,371,000.00
  • MXE N/A
  • Revenue This Year
  • KRRO $116.91
  • MXE N/A
  • Revenue Next Year
  • KRRO N/A
  • MXE N/A
  • P/E Ratio
  • KRRO N/A
  • MXE N/A
  • Revenue Growth
  • KRRO N/A
  • MXE N/A
  • 52 Week Low
  • KRRO $5.42
  • MXE $8.40
  • 52 Week High
  • KRRO $56.69
  • MXE $11.51
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 21.22
  • MXE 56.81
  • Support Level
  • KRRO $5.42
  • MXE $11.61
  • Resistance Level
  • KRRO $6.59
  • MXE $11.93
  • Average True Range (ATR)
  • KRRO 1.20
  • MXE 0.19
  • MACD
  • KRRO -0.82
  • MXE -0.00
  • Stochastic Oscillator
  • KRRO 0.70
  • MXE 69.26

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

Share on Social Networks: